We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury.
- Authors
Barroso, Lívia Corrêa; Silveira, Kátia Daniela; Lima, Cristiano Xavier; Borges, Valdinéria; Bader, Michael; Rachid, Milene; Souza Santos, Robson Augusto; Souza, Danielle Gloria; Simões e Silva, Ana Cristina; Teixeira, Mauro Martins
- Abstract
Renal ischemia and reperfusion (I/R) is the major cause of acute kidney injury in hospitalized patients. Mechanisms underlying reperfusion-associated injury include recruitment and activation of leukocytes and release of inflammatory mediators. In this study, we investigated the renal effects of acute administration of AVE0991, an agonist of Mas, the angiotensin-(1-7) receptor, the angiotensin-(1-7) receptor, in a murine model of renal I/R. Male C57BL/6 wild-type or Mas-/- mice were subjected to 30min of bilateral ischemia and 24 h of reperfusion. Administration of AVE0991 promoted renoprotective effects, as seen by improvement of function, decreased tissue injury, prevention of local and remote leucocyte infiltration, and release of the chemokine, CXCL1. I/R injury was similar in WT and Mas-/- mice, suggesting that endogenous activation of this receptor does not control renal damage under baseline conditions. In conclusion, pharmacological interventions using Mas receptor agonists may represent a therapeutic opportunity for the treatment of renal I/R injury.
- Subjects
KIDNEY physiology; KIDNEY injuries; ACE inhibitors; ANIMAL experimentation; CELL physiology; CELL receptors; CREATININE; CLINICAL drug trials; KIDNEY diseases; MICE; URINALYSIS; DESCRIPTIVE statistics
- Publication
International Journal of Hypertension, 2012, p1
- ISSN
2090-0384
- Publication type
Article
- DOI
10.1155/2012/808726